VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CALM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CALMCal-Maine Foods, Inc.
$73.13$3.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCALMCash Flow

Cal-Maine Foods, Inc. (CALM) Cash Flow Statement

30Y historyFree accessUpdated daily

Cash conversion has deteriorated as operating cash flow turned negative relative to net income (OCF/NI -0.17) and FCF margin fell to -3.9% in 2026Q4, yet cumulative OCF of $2.09B over ten quarters underscores cyclical earnings quality.

Income StatementBalance SheetCash FlowRatios

CALM Cash Flow Statement

Annual statement

CALM Cash Flow Statement

Cal-Maine Foods, Inc. (CALM) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricMay'26May'25May'24May'23May'22May'21May'20May'19May'18May'17May'16May'15May'14May'13May'12May'11May'10May'09May'08May'07May'06May'05May'04May'03May'02May'01May'00May'99May'98May'97
Cash from Operations483.01M1.23B451.4M863.01M126.21M26.14M73.61M115.08M200.41M-49.32M381.84M195.33M123.92M57.54M98.06M62.31M116.67M111.28M158.42M59.72M20.93M9.61M85.14M30.73M264K30.42M-11.07M24.1M24.9M32.5M
Operating CF Margin %16.59%28.83%19.4%27.43%7.1%1.94%5.45%8.45%13.33%-4.59%20.01%12.39%8.6%4.47%8.81%6.61%12.82%11.98%17.3%9.99%4.38%2.56%14.88%7.93%0.08%8.49%-3.85%8.37%8.06%11.11%
Operating CF Growth %-60.69%172.22%-47.69%583.79%382.89%-64.49%-36.04%-42.58%506.39%-112.92%95.48%57.63%115.37%-41.32%57.37%-46.59%4.84%-29.75%165.25%185.34%117.71%-88.71%177.04%11540.53%-99.13%374.92%-145.92%-3.21%-23.38%28.46%
Net Income316.68M1.22B277.89M756.73M132.44M2.06M18.33M55.06M126.2M-74.43M318.05M162.28M109.81M50.76M89.97M58.27M65.53M79.5M151.86M36.66M-1.01M-10.36M66.44M12.21M-10.57M6.82M-17.38M5.1M5.4M14.8M
Depreciation & Amortization124.34M94.02M80.24M72.23M68.39M59.48M58.1M54.65M54.03M49.11M44.59M40.71M37.2M34.17M30.75M30.75M31.79M28.08M25.32M21.48M20.57M16.44M16.84M16.62M17.31M17.54M15.81M12.2M12M10.6M
Stock-Based Compensation004.36M4.21M4.06M3.78M3.62M3.62M3.47M3.43M3.07M2.27M1.27M411K-702K-2.39M-533K-2.72M1.65M00000000000
Deferred Taxes67.36M11.57M-9.67M24.47M5.68M22.35M10.28M6.12M-33.81M14.83M19.39M5.11M7.63M-5.75M5.33M10.35M2.07M11.04M3.66M1.21M985K-710K3.55M7.04M241K3.41M-4.71M-100K800K2.9M
Other Non-Cash Items6.01M6.33M-3.01M-1.49M-5.27M4.53M3.6M-3.76M-1.29M2.06M-7.38M-2.42M-2.48M-2.32M-46.35M-8.64M-3.49M-2.87M-4.37M196K768K-511K-6.23M-769K290K62K-1.24M-600K0-300K
Working Capital Changes-31.4M-103.19M101.6M6.86M-79.09M-66.06M-20.32M-612K51.83M-44.33M4.11M-12.62M-29.51M-19.74M19.06M-26.03M21.3M-1.73M-19.71M191K-378K4.75M4.54M-4.37M-7M2.59M-3.54M7.5M6.7M4.5M
Change in Receivables139.75M-105M-27.57M58.13M-93.9M-33.49M-17.68M16.01M-28.38M-37.22M21.16M-18.96M-2.28M-21.67M0013.11M-3.58M003.24M4.83M00-7.39M2.3M-3.82M1.9M-300K1.7M
Change in Inventory-34.98M-12.22M28.8M-21.1M-36.15M-31.16M-9.7M-2.29M-7.95M2.39M-8.54M-143K8.91M-6.38M-7.14M-16.11M5.31M-2.91M-14.56M47K2.14M3.62M-756K-4.9M1.01M-3.21M1.42M6M3.7M1.2M
Change in Payables-8.34M65.31M9.35M-2.85M54.78M-1.41M17.68M-14.34M28.38M-9.49M-8.51M6.49M-8.14M8.31M21.89M12.28M2.89M06.59M0006.75M0000000
Cash from Investing-507.14M-579.52M-412.59M-375.11M-117.02M-44.19M-61.37M-47.82M-163.85M56.13M-212.55M-141.63M-99.38M-88.34M-27.05M-30.61M-61.55M-122.49M-31.34M-49.27M-22.87M-23.66M-44.03M-11.81M-14.38M-12.96M-59.97M-26.8M-18.1M-20.6M
Capital Expenditures-151.22M-161.25M-147.12M-136.57M-72.4M-95.07M-124.18M-67.99M-19.67M-66.66M-76.13M-82.26M-59.19M-26.29M-26.84M-20.74M-20.79M-26.11M-31.69M-23.47M-12.37M-11.98M-10.67M-12.55M-15.55M-14.06M-27.92M-28.1M-18.6M-16.2M
CapEx % of Revenue5.19%3.78%6.32%4.34%4.07%7.05%9.19%4.99%1.31%6.2%3.99%5.22%4.11%2.04%2.41%2.2%2.28%2.81%3.46%3.92%2.59%3.19%1.86%3.24%4.77%3.92%9.73%9.76%6.02%5.54%
Acquisitions-452.24M-112.31M-54.11M-1.67M-47.82M3.39M-44.65M-22.16M-4.1M-105.72M-33.96M-8.16M-11.55M-74.91M01.91M-508K-91.22M-12.05M-12.05M-23.76M879K0000-35.58M000
Investments------------------------------
Other Investing003.27M2.08M8.74M6.66M10.42M9.48M7.54M6.67M8.29M4.52M5.82M6.47M39.42M8.42M6.95M128K15.05M754K2.88M1.36M3M734K1.18M1.1M3.53M1.3M500K-4.4M
Cash from Financing-362.75M-386.72M-93.76M-254.16M-7.46M-2.72M-3.36M-46.45M-5.7M-18.3M-148.91M-59.55M-35M-41.34M-31.56M-73.48M-22.55M-16.76M-47.26M-8.72M-4.99M-17.25M-10.57M-17.7M5.86M-10.88M41.38M-2.2M10.6M7.9M
Debt Issued (Net)0-2.48M-214K-224K-215K-205K-1.7M-3.75M-4.85M-16.51M-25.29M-10.23M-10.74M-11.2M-11.94M-46.51M-3.82M18.08M-28.23M-1.7M-3.92M-7.04M-18.21M-17.7M7.02M-8.9M-4.56M1.8M11.1M-4M
Equity Issued (Net)-131.12M-53.95M-1.69M-1.64M-1.13M-871K-910K-985K-1.13M-1.72M-1.76M531K279K380K318K143K0427K626K262K103K-9.03M8.38M0-571K-1.37M46.55M-3.5M-200K10.2M
Dividends Paid-231.62M-330.29M-91.86M-252.29M-6.12M-1.65M0-41.71M00-120.94M-48.91M-24.53M-30.52M-19.94M-24.88M-19.04M-35.27M-19.65M-1.17M-1.17M-1.18M-746K0-591K-607K-611K-600K-300K0
Share Repurchases-131.12M-53.95M-1.69M-1.64M-1.13M-871K-910K-985K-1.13M-1.72M-1.76M0000000000-9.34M00-571K-1.37M-1.24M-3.5M-300K-400K
Other Financing00003K5K-755K0279K-73K-918K-940K000-2.23M308K00-6.1M0000000100K01.7M
Net Change in Cash-386.88M262.51M-54.95M233.74M1.73M-20.78M8.88M20.82M30.87M-11.48M20.38M-5.85M-10.46M-72.14M39.45M-41.77M32.57M-27.98M79.83M1.74M-6.93M-31.29M30.54M1.21M-8.25M6.59M-29.66M-4.9M10.6M7.9M
Free Cash Flow331.79M1.07B304.28M726.44M53.81M-68.93M-50.57M47.1M180.74M-115.97M305.71M113.07M64.73M31.25M71.21M41.57M95.88M85.17M126.73M36.25M8.56M-2.36M74.47M18.18M-15.29M16.36M-38.99M-4M6.3M16.3M
FCF Margin %11.4%25.05%13.08%23.09%3.03%-5.11%-3.74%3.46%12.03%-10.79%16.02%7.17%4.49%2.43%6.4%4.41%10.53%9.17%13.84%6.06%1.79%-0.63%13.01%4.69%-4.69%4.57%-13.58%-1.39%2.04%5.57%
FCF Growth %-68.92%250.84%-58.11%1250.01%178.06%-36.31%-207.37%-73.94%255.85%-137.94%170.38%74.67%107.16%-56.12%71.32%-56.65%12.58%-32.79%249.58%323.55%462.21%-103.17%309.49%218.95%-193.43%141.97%-874.7%-163.49%-61.35%-1.21%
FCF per Share6.9421.836.2314.881.10-1.42-1.040.973.73-2.406.322.331.340.651.490.872.011.792.670.770.18-0.051.530.38-0.330.34-0.80-0.080.120.19
FCF Conversion (FCF/Net Income)1.53x1.01x1.62x1.14x0.95x12.69x4.00x2.12x1.59x0.66x1.21x1.21x1.13x1.14x1.09x1.02x1.72x1.40x1.04x1.63x-20.66x-0.93x1.28x2.52x-0.02x4.46x0.64x4.73x4.61x2.20x
Interest Paid000561K379K508K498K644K001.07M2.31M3.15M3.54M4.41M6.45M6.88M6.16M000000000000
Taxes Paid0426.17M35.1M258.25M1.75M995K32K36.31M00166.84M75.53M41.63M42.67M27.07M28.93M14.38M42.34M000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Egg price normalization

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

Earnings Quality Deteriorates Sharply

Operating cash flow turned negative relative to net income in 2026Q4, with OCF/NI at -0.17, as reported in quarterly filings, signaling a breakdown in earnings quality.

The OCF/NI ratio swung from a healthy 2.05 in 2026Q3 to -0.17 in 2026Q4, indicating that reported losses are not fully reflecting cash generation. The negative working capital change of -$35.7M in 2026Q4 suggests that cash outflows are outpacing accrual-based earnings, likely due to inventory build-up or receivable collections. This divergence warrants close monitoring as it may indicate that the company is funding operations through cash reserves during a demand downturn.

Free Cash Flow Collapses Post-Peak

Free cash flow margin plummeted from 36.8% in 2025Q3 to -3.9% in 2026Q4, as per financial statements, reflecting the full unwinding of the HPAI-driven pricing windfall.

The FCF trajectory shows a dramatic reversal from a peak of $521.8M in 2025Q3 to a negative $21.4M in 2026Q4. This decline is consistent with the revenue normalization and margin compression observed in the income statement, where gross margins fell from 50.5% to 6.2%. The negative FCF in the latest quarter suggests that the company is now consuming cash, which may pressure its ability to maintain its variable dividend policy.

Capital Intensity Rises Amid Transition

CapEx as a percentage of revenue increased from 3.5% in 2025Q3 to 5.0% in 2026Q4, based on reported figures, indicating continued investment in cage-free conversion and flock replacement.

Despite the revenue decline, CapEx has remained relatively stable in absolute terms, ranging from $27.5M to $51.1M over the past ten quarters. This suggests that management is prioritizing long-term capacity and regulatory compliance over short-term cash preservation. The elevated capital intensity during a downturn may indicate that the company is positioning for the next upcycle, but it also increases the risk of cash burn if the demand environment remains weak.

Working Capital Swing Amplifies Volatility

Working capital changes swung from a positive $40.7M in 2025Q3 to a negative $120.2M in 2025Q2, as per quarterly data, highlighting the cyclicality of egg pricing and inventory.

The working capital line has been highly volatile, with large positive contributions during peak pricing quarters and significant outflows during troughs. In 2026Q4, the negative working capital change of -$35.7M suggests that the company is building inventory or facing slower collections as egg prices fall. This pattern indicates that cash flow is heavily influenced by commodity price cycles, making it difficult to predict short-term liquidity.

Capital Returns Persist Despite Cash Strain

Dividends and buybacks totaled $46.9M in 2026Q4, as reported, even as free cash flow turned negative, suggesting a commitment to shareholder returns despite cyclical pressures.

The company continued to pay dividends and repurchase shares in 2026Q4, with combined outflows of $46.9M, exceeding the negative FCF of -$21.4M. This indicates that management is drawing down cash reserves to maintain distributions, which may be unsustainable if the downturn persists. However, the fortress balance sheet with over $500M in cash provides a buffer, though investors should monitor whether the variable dividend policy will be adjusted in future quarters.

Cumulative Cash Generation Outpaces Earnings

Over the last ten quarters, cumulative operating cash flow of $2.09B exceeded cumulative net income of $1.99B, as per financial statements, indicating high earnings quality over the cycle.

Despite the recent deterioration, the cumulative OCF/NI ratio of 1.05 suggests that, on a multi-quarter basis, cash generation has been slightly stronger than reported earnings. This is partly due to non-cash charges like D&A and favorable working capital swings during peak quarters. However, the recent negative divergence in 2026Q4 may signal a turning point, and investors should watch whether the cumulative gap narrows further.

Cash Flow Obscures Biological Asset Costs

The cash flow statement does not separately disclose flock replacement costs, which are embedded in CapEx and COGS, as per standard accounting, potentially masking the true cost of maintaining production capacity.

Cal-Maine's biological assets (hens) are depreciated and replaced through CapEx, but the cash flow statement does not break out maintenance vs. growth CapEx. This makes it difficult to assess whether the company is adequately investing to sustain its flock, especially during periods of HPAI-related losses. Additionally, the timing of insurance recoveries and government indemnities may create lumpy cash inflows that are not indicative of core operations, as seen in prior quarters.

CALM — Frequently Asked Questions

Quick answers to the most common questions about buying CALM stock.

How much cash does Cal-Maine Foods, Inc. (CALM) generate from operations?

Cal-Maine Foods, Inc. (CALM) generated $483.0M in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.

What is Cal-Maine Foods, Inc.'s free cash flow?

Cal-Maine Foods, Inc. (CALM) generated $331.8M in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Cal-Maine Foods, Inc.'s capital expenditure (CapEx)?

Cal-Maine Foods, Inc. (CALM) spent $151.2M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Cal-Maine Foods, Inc. distribute cash to shareholders?

In 2026, Cal-Maine Foods, Inc. (CALM) returned $231.6M to shareholders via cash dividends and spent $131.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.